Skip to main content
Top
Published in: Surgical Endoscopy 7/2019

01-07-2019

Comparison of the short-term and long-term outcomes of surgical treatment versus endoscopic treatment for early esophageal squamous cell neoplasia larger than 2 cm: a retrospective study

Authors: Baisi Yuan, Leilei Liu, Hairong Huang, Demin Li, Yi Shen, Bo Wu, Jiong Liu, Miaofang Yang, Zhenkai Wang, Heng Lu, Yuxiu Liu, Lianming Liao, Fangyu Wang

Published in: Surgical Endoscopy | Issue 7/2019

Login to get access

Abstract

Background

NCCN Guidelines of esophageal cancer recommend that endoscopic therapy is considered “preferred” for patients with limited early-stage disease less than or equal to 2 cm. However, there is currently no definite evidence to support either endoscopic therapy or esophagectomy for early esophageal cancer larger than 2 cm. We aimed to explore the optimal treatment for this condition.

Methods

From January 2010 to June 2016, 116 patients with early esophageal neoplasia [high-grade dysplasia (HGD), lamina propria and muscularis mucosae (T1a) cancer, selected superficial submucosa (T1b) cancer without lymph node metastases] larger than 2 cm and treated either surgically or endoscopically were included.

Results

Endoscopic therapy was performed in 69 patients and esophagectomy in 47 patients, respectively. The median follow-up time was 43.8 months in the endoscopic cohort and 49.4 months in the surgical cohort. The overall survival was similar between the two cohorts (97.1% vs. 91.5%, P = 0.18). Survival without readmission for treatment-related complicates was also similar. Minor and severe procedure-related complications occurred more often in the surgical cohort than in the endoscopic cohort (63.8% vs. 43.5% and 8.5% vs. 0 respectively, P < 0.05 for both). Four patients in the endoscopic cohort had to undergo additional esophagectomy and were alive during follow-up. There were no procedure-related deaths in the endoscopic cohort, whereas two deaths occurred in the surgical cohort. Recurrence occurred in nine patients in the endoscopic group (13%): six with local recurrence, one with residual neoplasia and two with metachronous neoplasia. None of them died after repeated endoscopic treatments.

Conclusions

Efficacy was similar between endoscopic therapy and esophagectomy in the treatment of early esophageal squamous cell neoplasia larger than 2 cm and endoscopic therapy was associated with fewer and manageable complications. We recommend endoscopic treatment should be preferred selected for early esophageal neoplasia larger than 2 cm.
Literature
1.
go back to reference Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB (2003) Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98(7):1627–1633PubMed Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB (2003) Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98(7):1627–1633PubMed
2.
go back to reference ASGE Standards of Practice Committee, Evans JA, Early DS, Chandraskhara V, Chathadi KV, Fanelli RD, Fisher DA, Foley KQ, Hwang JH, Jue TL, Pasha SF, Sharaf R, Shergill AK, Dominitz JA, Cash BD, American Society for Gastrointestinal Endoscopy (2013) The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 77(3):328–334. https://doi.org/10.1016/j.gie.2012.10.001 CrossRef ASGE Standards of Practice Committee, Evans JA, Early DS, Chandraskhara V, Chathadi KV, Fanelli RD, Fisher DA, Foley KQ, Hwang JH, Jue TL, Pasha SF, Sharaf R, Shergill AK, Dominitz JA, Cash BD, American Society for Gastrointestinal Endoscopy (2013) The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 77(3):328–334. https://​doi.​org/​10.​1016/​j.​gie.​2012.​10.​001 CrossRef
4.
go back to reference Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, Manner H, Guenter E, Huijsmans J, Vieth M, Stolte M, Ell C (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57(9):1200–1206. https://doi.org/10.1136/gut.2007.142539 CrossRefPubMed Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, Manner H, Guenter E, Huijsmans J, Vieth M, Stolte M, Ell C (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57(9):1200–1206. https://​doi.​org/​10.​1136/​gut.​2007.​142539 CrossRefPubMed
5.
go back to reference Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A, Nachbar L, Huijsmans J, Vieth M, Stolte M (2007) Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 65(1):3–10CrossRefPubMed Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A, Nachbar L, Huijsmans J, Vieth M, Stolte M (2007) Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 65(1):3–10CrossRefPubMed
6.
go back to reference Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma: an American single-center experience. Am J Gastroenterol 104(11):2684–2692. https://doi.org/10.1038/ajg.2009.465 CrossRefPubMed Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma: an American single-center experience. Am J Gastroenterol 104(11):2684–2692. https://​doi.​org/​10.​1038/​ajg.​2009.​465 CrossRefPubMed
7.
go back to reference Peters FP, Kara MA, Rosmolen WD, ten Kate FJ, Krishnadath KK, van Lanschot JJ, Fockens P, Bergman JJ (2006) Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia: a prospective study. Am J Gastroenterol 101(7):1449–1457CrossRefPubMed Peters FP, Kara MA, Rosmolen WD, ten Kate FJ, Krishnadath KK, van Lanschot JJ, Fockens P, Bergman JJ (2006) Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia: a prospective study. Am J Gastroenterol 101(7):1449–1457CrossRefPubMed
13.
go back to reference Moraca RJ, Low DE (2006) Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 141(6):545–549CrossRefPubMed Moraca RJ, Low DE (2006) Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 141(6):545–549CrossRefPubMed
15.
go back to reference Thota PN, Sada A, Sanaka MR, Jang S, Lopez R, Goldblum JR, Liu X, Dumot JA, Vargo J, Zuccarro G (2017) Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett’s esophagus with high-grade dysplasia and early cancer. Surg Endosc 31(3):1336–1341CrossRefPubMed Thota PN, Sada A, Sanaka MR, Jang S, Lopez R, Goldblum JR, Liu X, Dumot JA, Vargo J, Zuccarro G (2017) Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett’s esophagus with high-grade dysplasia and early cancer. Surg Endosc 31(3):1336–1341CrossRefPubMed
16.
go back to reference Bergeron EJ, Lin J, Chang AC, Orringer MB, Reddy RM (2014) Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies. J Thorac Cardiovasc Surg 147(2):765–771CrossRefPubMed Bergeron EJ, Lin J, Chang AC, Orringer MB, Reddy RM (2014) Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies. J Thorac Cardiovasc Surg 147(2):765–771CrossRefPubMed
17.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
19.
go back to reference Fujita H, Sueyoshi S, Yamana H, Shinozaki K, Toh U, Tanaka Y, Mine T, Kubota M, Shirouzu K, Toyonaga A, Harada H, Ban S, Watanabe M, Toda Y, Tabuchi E, Hayabuchi N, Inutsuka H (2001) Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg 25(4):424–431CrossRefPubMed Fujita H, Sueyoshi S, Yamana H, Shinozaki K, Toh U, Tanaka Y, Mine T, Kubota M, Shirouzu K, Toyonaga A, Harada H, Ban S, Watanabe M, Toda Y, Tabuchi E, Hayabuchi N, Inutsuka H (2001) Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg 25(4):424–431CrossRefPubMed
20.
go back to reference Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Krishnadath KK, Nichols FC 3rd, Lutzke LS, Borkenhagen LS (2007) Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 132(4):1226–1233CrossRefPubMedPubMedCentral Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Krishnadath KK, Nichols FC 3rd, Lutzke LS, Borkenhagen LS (2007) Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 132(4):1226–1233CrossRefPubMedPubMedCentral
22.
go back to reference Rosmolen WD, Boer KR, de Leeuw RJ, Gamel CJ, van Berge Henegouwen MI, Bergman JJ, Sprangers MA (2010) Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barrett’s esophagus. Endoscopy 42(7):525–531. https://doi.org/10.1055/s-0029-1244222 CrossRef Rosmolen WD, Boer KR, de Leeuw RJ, Gamel CJ, van Berge Henegouwen MI, Bergman JJ, Sprangers MA (2010) Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barrett’s esophagus. Endoscopy 42(7):525–531. https://​doi.​org/​10.​1055/​s-0029-1244222 CrossRef
25.
go back to reference Hollis AC, Quinn LM, Hodson J, Evans E, Plowright J, Begum R, Mitchell H, Hallissey MT, Whiting JL, Griffiths EA (2017) Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer. J Surg Oncol 116(8):1114–1122CrossRefPubMed Hollis AC, Quinn LM, Hodson J, Evans E, Plowright J, Begum R, Mitchell H, Hallissey MT, Whiting JL, Griffiths EA (2017) Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer. J Surg Oncol 116(8):1114–1122CrossRefPubMed
27.
go back to reference Pacifico RJ, Wang KK, Wongkeesong LM, Buttar NS, Lutzke LS (2003) Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett’s esophagus. Clin Gastroenterol Hepatol 1(4):252–257CrossRefPubMed Pacifico RJ, Wang KK, Wongkeesong LM, Buttar NS, Lutzke LS (2003) Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett’s esophagus. Clin Gastroenterol Hepatol 1(4):252–257CrossRefPubMed
28.
go back to reference Reed MF, Tolis G Jr, Edil BH, Allan JS, Donahue DM, Gaissert HA, Moncure AC, Wain JC, Wright CD, Mathisen DJ (2005) Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg 79(4):1110–1115CrossRefPubMed Reed MF, Tolis G Jr, Edil BH, Allan JS, Donahue DM, Gaissert HA, Moncure AC, Wain JC, Wright CD, Mathisen DJ (2005) Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg 79(4):1110–1115CrossRefPubMed
29.
go back to reference Hulscher F, van Sandick J, de Boer A, Wijnhoven B, Tijssen J, Fockens P (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347(21):1662–1669CrossRef Hulscher F, van Sandick J, de Boer A, Wijnhoven B, Tijssen J, Fockens P (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347(21):1662–1669CrossRef
30.
go back to reference Jamieson G, Mathew G, Ludemann R, Wayman J, Myers J, Devitt P (2004) Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 5(8):943–947CrossRef Jamieson G, Mathew G, Ludemann R, Wayman J, Myers J, Devitt P (2004) Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 5(8):943–947CrossRef
31.
go back to reference Mohiuddin K, Dorer R, El Lakis MA, Hahn H, Speicher J, Hubka M, Low DE (2016) Outcomes of surgical resection of T1bN0 esophageal cancer and assessment of endoscopic mucosal resection for identifying low-risk cancers appropriate for endoscopic therapy. Ann Surg Oncol 23(8):2673–2678CrossRefPubMed Mohiuddin K, Dorer R, El Lakis MA, Hahn H, Speicher J, Hubka M, Low DE (2016) Outcomes of surgical resection of T1bN0 esophageal cancer and assessment of endoscopic mucosal resection for identifying low-risk cancers appropriate for endoscopic therapy. Ann Surg Oncol 23(8):2673–2678CrossRefPubMed
32.
go back to reference Wang S, Huang Y, Xie J, Zhuge L, Shao L, Xiang J, Zhang Y, Sun Y, Hu H, Chen S, Lerut T, Luketich JD, Zhang J, Chen H (2018) Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis. Surg Endosc 32(3):1441–1448CrossRefPubMed Wang S, Huang Y, Xie J, Zhuge L, Shao L, Xiang J, Zhang Y, Sun Y, Hu H, Chen S, Lerut T, Luketich JD, Zhang J, Chen H (2018) Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis. Surg Endosc 32(3):1441–1448CrossRefPubMed
33.
go back to reference Smith I, Kahaleh M (2015) Endoscopic versus surgical therapy for Barrett’s esophagus neoplasia. Expert Rev Gastroenterol Hepatol 9(1):31–35CrossRefPubMed Smith I, Kahaleh M (2015) Endoscopic versus surgical therapy for Barrett’s esophagus neoplasia. Expert Rev Gastroenterol Hepatol 9(1):31–35CrossRefPubMed
35.
go back to reference Mariette C, Finzi L, Piessen G, Van Seuningen I, Triboulet JP (2005) Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg 29(1):39–45CrossRefPubMed Mariette C, Finzi L, Piessen G, Van Seuningen I, Triboulet JP (2005) Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg 29(1):39–45CrossRefPubMed
Metadata
Title
Comparison of the short-term and long-term outcomes of surgical treatment versus endoscopic treatment for early esophageal squamous cell neoplasia larger than 2 cm: a retrospective study
Authors
Baisi Yuan
Leilei Liu
Hairong Huang
Demin Li
Yi Shen
Bo Wu
Jiong Liu
Miaofang Yang
Zhenkai Wang
Heng Lu
Yuxiu Liu
Lianming Liao
Fangyu Wang
Publication date
01-07-2019
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 7/2019
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-018-6524-2

Other articles of this Issue 7/2019

Surgical Endoscopy 7/2019 Go to the issue